Wei Shen Tan

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (8)

Neema Navai

UNITED STATES

View details

Emma Hall

Institute of Cancer Research

UNITED KINGDOM

View details

Roger Li

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES

View details

Ashish Kamat

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Nikhil Vasdev

Professor and Chair of Robotic Surgery and Urology

University of Hertfordshire

UNITED KINGDOM

View details

Steven Penegar

Institute of Cancer Research

UNITED KINGDOM

View details

Joanna Wong

University Hospital

UNITED KINGDOM

View details

Alberto Martini

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Wei Shen Tan

Research Interests

Explore related searches

Contact this professor

Articles (12)

‘Case of the Month’ from The University of Texas MD Anderson Cancer Center, Houston, Texas, USA: ependymoma of the urinary bladder

Influence of lamina propria invasion extension on T1 high‐grade non‐muscle‐invasive bladder cancer in patients undergoing BCG or radical cystectomy

Clinical trial design for non-muscle-invasive bladder cancer

Bacillus Calmette–Guérin (BCG) unresponsive non‐muscle‐invasive bladder cancer: are the subgroups equal?

International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active Surveillance

Impact of age >70 years on oncological outcomes in patients with NMIBC treated with BCG

Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin–unresponsive Non–muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes

Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer

Reply to Arnulf Stenzl, Morgan Rouprêt, J. Alfred Witjes, Paolo Gontero. High-quality Transurethral Resection of Bladder Tumour Needs Additional Forms of Tumour Delineation. Eur Urol 2023;83:193–4

Evolving systemic management of urothelial cancers

Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials

Reply by Authors

Collaborators (8)

Neema Navai

Emma Hall

Roger Li

Ashish Kamat

Nikhil Vasdev

Steven Penegar

Joanna Wong

Alberto Martini

Make your next move.